long-term effects of glp-1 receptor agonists Adverse GLP-1: Genetic Variants Related to

Full benefits typically develop over 8-12 weeks as your body adjusts to the medication

In the meantime, GLP-1s represent a clinically relevant tool for improving metabolic resilience, reducing systemic inflammatory stress, and supporting long-term physiological function when applied appropriately

GI, gastrointestinal

The first oral (pill) form of a GLP-1 (semaglutide, brand name Wegovy) became available in January 2026

The most common study treatment-related adverse effects were GI disorders such as vomiting, abdominal distention, and nausea, however, mostly of mild intensity

GLP-1 drugs can be helpful while you are taking them, but gastric sleeve changes the trajectory of your weight and metabolism in a much more lasting way